These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25245211)

  • 21. Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic discs to ceftazidime and co-trimoxazole.
    Vorachit M; Lam K; Jayanetra P; Costerton JW
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2000-2. PubMed ID: 7694545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei.
    Webb JR; Price EP; Somprasong N; Schweizer HP; Baird RW; Currie BJ; Sarovich DS
    Future Microbiol; 2018 Sep; 13(12):1403-1418. PubMed ID: 30256166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of biapenem against Burkholderia pseudomallei.
    Thamlikitkul V; Trakulsomboon S
    Int J Antimicrob Agents; 2010 May; 35(5):514. PubMed ID: 20188524
    [No Abstract]   [Full Text] [Related]  

  • 24. Susceptibility of Burkholderia pseudomallei to tigecycline and other antimicrobials.
    Sam IC; See KH; Puthucheary SD
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):308-9. PubMed ID: 20356698
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination.
    Lumbiganon P; Tattawasatra U; Chetchotisakd P; Wongratanacheewin S; Thinkhamrop B
    J Med Assoc Thai; 2000 Aug; 83(8):856-60. PubMed ID: 10998837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cutaneous melioidosis: report of a case].
    Li Q; Zeng HM; Zhang HJ
    Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):767-8. PubMed ID: 17374271
    [No Abstract]   [Full Text] [Related]  

  • 27. In-vitro activity of β-lactams/trimethoprim-sulfamethoxazole combinations against different strains of Burkholderia pseudomallei.
    Mohamad NI; Harun A; Hasan H; Deris ZZ
    Trop Biomed; 2022 Mar; 39(1):11-16. PubMed ID: 35225295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro antibiotic susceptibility compliance with efficacy of chemotherapy in infections due to pathogenic Burkholderias].
    Iliukhin VI; Senina TV; Trushkina MN; Shubnikova EV; Antonov IuV; Andropova NV
    Antibiot Khimioter; 2009; 54(7-8):19-23. PubMed ID: 20201399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melioidosis, phnom penh, Cambodia.
    Vlieghe E; Kruy L; De Smet B; Kham C; Veng CH; Phe T; Koole O; Thai S; Lynen L; Jacobs J
    Emerg Infect Dis; 2011 Jul; 17(7):1289-92. PubMed ID: 21762590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.
    Schweizer HP
    Future Microbiol; 2012 Dec; 7(12):1389-99. PubMed ID: 23231488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.
    Khosravi Y; Vellasamy KM; Mariappan V; Ng SL; Vadivelu J
    ScientificWorldJournal; 2014; 2014():132971. PubMed ID: 25379514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.
    Wuthiekanun V; Cheng AC; Chierakul W; Amornchai P; Limmathurotsakul D; Chaowagul W; Simpson AJ; Short JM; Wongsuvan G; Maharjan B; White NJ; Peacock SJ
    J Antimicrob Chemother; 2005 Jun; 55(6):1029-31. PubMed ID: 15886263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
    Feterl M; Govan B; Engler C; Norton R; Ketheesan N
    Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.
    Sam IC; See KH; Puthucheary SD
    J Clin Microbiol; 2009 May; 47(5):1556-8. PubMed ID: 19297597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melioidosis presenting as urinary tract infection in a previously healthy tourist.
    Carlson P; Seppänen M
    Scand J Infect Dis; 2000; 32(1):92-3. PubMed ID: 10716086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
    Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
    J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated liver abscesses in melioidosis.
    Mukhopadhya A; Balaji V; Jesudason MV; Amte A; Jeyamani R; Kurian G
    Indian J Med Microbiol; 2007 Apr; 25(2):150-1. PubMed ID: 17582188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
    Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
    Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melioidosis: antibiogram of cases in Singapore 1987-2007.
    Tan AL; Tan ML
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S101-2. PubMed ID: 19121668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cases of melioidosis in a university teaching hospital in Malaysia.
    Raja NS
    J Microbiol Immunol Infect; 2008 Apr; 41(2):174-9. PubMed ID: 18473106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.